Abstract:Longmin Chen, 1 Qing Zhou, 2 Xun Fang, 1 Qianqian Xu, 2 Yuan Zou, 2 Jing Zhang 2 1 Department of Rheumatology and Immunology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China Correspondence: Jing Zhang, Department of Respiratory and Critical Care Medicine, NHC Key Laboratory of Respiratory Disease, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Caidian, 430100, People's Republic of China, Email Background: Rheumatoid arthritis (RA) is a chronic and systemic autoimmune disease characterized by synovial inflammation and joint destruction. Despite progress in RA therapy, it remains difficult to achieve long-term remission in RA patients. Phosphodiesterase 3B (Pde3b) is a member of the phosphohydrolyase family that are involved in many signal transduction pathways. However, its role in RA is yet to be fully addressed. Methods: Studies were conducted in arthritic DBA/1 mice, a suitable mouse strain for collagen-induced rheumatoid arthritis (CIA), to dissect the role of Pde3b in RA pathogenesis. Next, RNAi-based therapy with Pde3b siRNA-loaded liposomes was assessed in a CIA model. To study the mechanism involved, we investigated the effect of Pde3b knockdown on macrophage polarization and related signaling pathway. Results: We demonstrated that mice with CIA exhibited upregulated Pde3b expression in macrophages. Notably, intravenous administration of liposomes loaded with Pde3b siRNA promoted the macrophage anti-inflammatory program and alleviated CIA in mice, as indicated by the reduced inflammatory response, synoviocyte infiltration, and bone and cartilage erosion. Mechanistic study revealed that depletion of Pde3b increased cAMP levels, by which it enhanced PKA-CREB-C/EBPβ pathway to transcribe the expression of anti-inflammatory program-related genes. Conclusion: Our results support that Pde3b is involved in the pathogenesis of RA, and Pde3b siRNA-loaded liposomes might serve as a promising therapeutic approach against RA. Keywords: rheumatoid arthritis, Pde3b, liposomes, macrophages Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease affecting ~0.5–1.0% of the population worldwide. 1 RA is characterized by articular inflammation, often with accumulating joint damage and irreversible disability if insufficiently treated. Currently, RA is still regarded as an incurable disease, and glucocorticoids (GCs), non-steroidal anti-inflammatory drugs (NSAIDs), and disease-modifying anti-rheumatic drugs (DMARDs) are the most commonly used medications in clinic. 2 Although they could relieve symptoms and delay arthritis progression, frequent administration and high dosage are often needed to achieve optimal disease control, which inevitably result in poor compliance and untoward adverse effects. 2,3 Over the past two decades, we have witnessed the evolution and approval of a variety of biological agents, ie, antibodies against tumor necrosis factor (TNF) and interleukin (IL)-6 receptor. However, biologic agents are expensive, and approximately 30–40% of patients do not respond well, accompanied with increased risk of infections. 4,5 Thus, novel therapeutic strategies for RA are urgently needed. The pathogenesis of RA involves a broad range of inflammatory processes, including dysregulated cytokine production and complicated crosstalk among inflammatory cells. 6 Among these cells, macrophages play a crucial role in shifting synovial inflammation towards a pathological state versus an adaptive response. Macrophages are classified into two subtypes, classically activated macrophages (pro-inflammatory macrophages) and alternatively activated macrophages (anti-inflammatory macrophages). 7,8 In the healthy joint, macrophages typically express anti-inflammatory markers, including arginase 1 (Arg1) and the mannose receptor CD206, and produce immune-regulatory cytokines such as IL-10, IL-13, and transforming growth factor (TGF)-β, which contribute to the maintenance of tissue homeostasis. During RA, however, pro-inflammatory macrophages that secret inflammatory mediators such as IL-1β, IL-6, and TNF-α accumulate in the swollen inflamed synovial tissue and promote tissue destruction and bone erosion. 9 In this respect, shifting synovial macrophages -Abstract Truncated-

FGFR3 Deficiency Enhances CXCL12-dependent Chemotaxis of Macrophages Via Upregulating CXCR7 and Aggravates Joint Destruction in Mice.

Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice

Targeting FGFR3 is a Useful Therapeutic Strategy for Rheumatoid Arthritis Treatment

Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis

CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts

FGFR3 deficient mice have accelerated fracture repair

CCL3/CCR1 Mediates CD14+CD16− Circulating Monocyte Recruitment in Knee Osteoarthritis Progression

Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32

Regulation of Pulmonary Fibrosis by Chemokine Receptor CXCR3.

Myeloid Vamp3 deletion attenuates CFA-induced inflammation and pain in mice via ameliorating macrophage infiltration and inflammatory cytokine production

SRGN promotes macrophage recruitment through CCL3 in osteoarthritis

Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization

Dorsal Root Ganglion Neuron-Derived Sfrp2 Promotes Macrophage Polarization to Regulate Gouty Arthritis

MLL3 Inhibits Apoptosis of Rheumatoid Arthritis Fibroblast-Like Synoviocytes and Promotes Secretion of Inflammatory Factors by Activating CCL2 and the NF-κB Pathway

Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway

Deficiency of histone deacetylases 3 in macrophage alleviates monosodium urate crystals-induced gouty inflammation in mice

Genetic inhibition of fibroblast growth factor receptor 1 in knee cartilage attenuates the degeneration of articular cartilage in adult mice.

Administration of Liposomal-Based Pde3b Gene Therapy Protects Mice Against Collagen-Induced Rheumatoid Arthritis via Modulating Macrophage Polarization

GRK2 Mediated Abnormal Transduction of PGE2-EP4-cAMP-CREB Signaling Induces the Imbalance of Macrophages Polarization in Collagen-Induced Arthritis Mice

Single-Cell Multi-Dimensional data analysis reveals the role of ARL4C in driving rheumatoid arthritis progression and Macrophage polarization dynamics

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke